Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.130
+0.010 (0.47%)
Aug 1, 2025, 4:00 PM - Market closed
Exscientia Revenue
Seer, Inc. had revenue of $4.21M in the quarter ending March 31, 2025, with 37.15% growth. This brings the company's revenue in the last twelve months to $15.31M, down -2.33% year-over-year. In the year 2024, Seer, Inc. had annual revenue of $14.17M, down -14.95%.
Revenue (ttm)
$15.31M
Revenue Growth
-2.33%
P/S Ratio
8.49
Revenue / Employee
$114,246
Employees
134
Market Cap
125.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.17M | -2.49M | -14.95% |
Dec 31, 2023 | 16.66M | 1.17M | 7.54% |
Dec 31, 2022 | 15.49M | 8.88M | 134.14% |
Dec 31, 2021 | 6.62M | 5.96M | 908.69% |
Dec 31, 2020 | 656.00K | 540.00K | 465.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 57.37B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SEER News
- 1 day ago - Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 10 days ago - Seer to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 2 months ago - Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults - GlobeNewsWire
- 2 months ago - Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency - GlobeNewsWire
- 2 months ago - Seer, Inc. (SEER) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - GlobeNewsWire
- 3 months ago - Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 5 months ago - Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript - Seeking Alpha